HER2 IHC Refresher Training

HER2 IHC Refresher Training

Global Ring Study HER2 IHC Testing in Breast Cancer

March 31st, 2023 (09:00 CEST), April 05th, 2023 (09:00 CEST), April 05th, 2023 (09:00 EDT), April 12th, 2023 (09:00 CEST), April 12th, 2023 (09:00 EDT), April 18th, 2023 (09:00 CEST)


Prof. Dr. med. Hans-Ulrich Schildhaus


Prof. Dr. med. Hans-Ulrich Schildhaus

Prof. Dr. med. Sunil Badve

Dr. med. Katja Schmitz

Dr. med. Fouad Alchami

Dear colleagues,

A precise HER2 assessment is the basis for the decision to treat breast cancer and for optimal patient care. Challenges in this process include accurate quantification of HER2 staining intensity, membrane or cytoplasmic staining, sample quality and the assay selection.

The focus of this particular HER2 IHC Refresher Training is to improve the skills to distinguish HER2 expression in the lower ranges across different HER2 assays.

Prof. Hans Ulrich Schildhaus


    Contact us

    If you have further questions or problems with the registration, you can also register by e-mail: Biomarker.Academy@dls.com

    You can contact us at any time if you have further questions about the issue of privacy and data protection by emailing our Global Privacy Officer at Compliance@dls.com or our external data protection officer:

    Dr. Barbara Tomasi
    Phone: +49 32 212296564

    We ensure, that the content of this educational course is designed product and serviceneutral. We assure that potential conflicts of interest between the organizer, the scientific lead and the speaker will be disclosed towards the participants (e.g. on the first slide of a presentation, an handout, link, download or notice). This event is sponsored by Daiichi Sankyo and AstraZeneca.